-
Signature
-
/s/ Jill Osato, Attorney-in-fact
-
Issuer symbol
-
ATEN
-
Transactions as of
-
11 Feb 2026
-
Net transactions value
-
-$2,060,000
-
Form type
-
4
-
Filing time
-
13 Feb 2026, 17:28:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Trivedi Dhrupad |
Chief Executive Officer, Director |
C/O A10 NETWORKS, INC., 2300 ORCHARD PARKWAY, SAN JOSE |
/s/ Jill Osato, Attorney-in-fact |
13 Feb 2026 |
0001570462 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ATEN |
Common Stock |
Sale |
$689,660 |
-33,333 |
-4.9% |
$20.69 |
648,748 |
11 Feb 2026 |
Direct |
F1, F2 |
| transaction |
ATEN |
Common Stock |
Sale |
$685,326 |
-33,333 |
-5.1% |
$20.56 |
615,415 |
12 Feb 2026 |
Direct |
F1, F3 |
| transaction |
ATEN |
Common Stock |
Award |
$0 |
+131,516 |
+21% |
$0.000000 |
746,931 |
12 Feb 2026 |
Direct |
F4 |
| transaction |
ATEN |
Common Stock |
Sale |
$685,014 |
-33,334 |
-4.5% |
$20.55 |
713,597 |
13 Feb 2026 |
Direct |
F1, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ATEN |
Performance-based Restricted Stock Units |
Award |
$0 |
+131,516 |
|
$0.000000 |
131,516 |
12 Feb 2026 |
Common Stock |
131,516 |
|
Direct |
F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: